Neurosense Therapeutics said it's producing its ALS therapy PrimeC at a commercial scale as it prepares for potential ...

Columnist Dagmar Munn considers when she decided to share the news that she had ALS — and it wasn't when she felt "ready" to ...

The ALS therapy ATLX-1282 was developed with AIchemab's platform, which uses AI to identify therapeutic targets for difficult ...

The nationwide event will cost $20, with all funds benefiting Augie's Quest, which was founded to fund research and raise ALS ...

Implanting a sensor in the brain helped detect intended speech and allowed control of a computer for a man with ALS in a ...

Implanting a sensor in a region of the brain that helps to control speech was shown in a U.S. study to not only decode the intended speech of a man with amyotrophic lateral sclerosis (ALS), but also ...